Summary of human West Nile virus vaccine meeting, 2024: Investigating barriers to development.
Saved in:
| Title: | Summary of human West Nile virus vaccine meeting, 2024: Investigating barriers to development. |
|---|---|
| Authors: | Nett RJ; Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, 3156 Rampart Road, Fort Collins, CO 80521, USA. Electronic address: gge5@cdc.gov., Brault AC; Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, 3156 Rampart Road, Fort Collins, CO 80521, USA. Electronic address: zlu5@cdc.gov., Lambert AJ; Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, 3156 Rampart Road, Fort Collins, CO 80521, USA. Electronic address: ahk7@cdc.gov., Agnihothram S; Office of Vaccines Research and Review, Food and Drug Administration, Silver Spring, MD, USA. Electronic address: sudhakar.agnihothram@fda.hhs.gov., Barrett ADT; Department of Pathology and Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA. Electronic address: abarrett@utmb.edu., Barzon L; Department of Molecular Medicine, University of Padova, and Microbiology and Virology Unit, Padova University Hospital, Padua, Italy. Electronic address: luisa.barzon@unipd.it., Clements DE; Hawaii Biotech, Inc., Honolulu, HI, USA. Electronic address: clements@hibiotech.com., Durbin A; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. Electronic address: adurbin1@jhu.edu., Kretschmer M; Maricopa County Department of Public Health, Phoenix, AZ, USA. Electronic address: melissa.kretschmer@maricopa.gov., Monath TP; Quigley BioPharma LLC, Leominster, MA, USA. Electronic address: tom@quigleybio.com., Mura M; Department of Public Health Threats, European Medicines Agency, Amsterdam, Netherlands. Electronic address: manuela.mura@ema.europa.eu., Pierson TC; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: piersontc@niaid.nih.gov., Prutzman K; Office of Vaccines Research and Review, Food and Drug Administration, Silver Spring, MD, USA. Electronic address: kirk.prutzman@fda.hhs.gov., Slifka MK; Najit Technologies, Inc., Beaverton, OR, USA, Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA. Electronic address: mslifka@najittech.com., Suthar MS; Department of Pediatrics, Center for Childhood Infections and Vaccines, Emory Vaccine Center, Department of Microbiology and Immunology, Emory School of Medicine, Atlanta, GA, USA. Electronic address: msuthar@emory.edu., Whitehead SS; Najit Technologies, Inc., Beaverton, OR, USA, Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA; Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: swhitehead@niaid.nih.gov., Staples JE; Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, 3156 Rampart Road, Fort Collins, CO 80521, USA. Electronic address: auv1@cdc.gov. |
| Source: | Vaccine [Vaccine] 2025 Dec 05; Vol. 68, pp. 127938. Date of Electronic Publication: 2025 Nov 05. |
| Publication Type: | Conference Proceedings |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41197444 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Summary of human West Nile virus vaccine meeting, 2024: Investigating barriers to development. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nett+RJ%22">Nett RJ</searchLink>; Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, 3156 Rampart Road, Fort Collins, CO 80521, USA. Electronic address: gge5@cdc.gov.<br /><searchLink fieldCode="AU" term="%22Brault+AC%22">Brault AC</searchLink>; Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, 3156 Rampart Road, Fort Collins, CO 80521, USA. Electronic address: zlu5@cdc.gov.<br /><searchLink fieldCode="AU" term="%22Lambert+AJ%22">Lambert AJ</searchLink>; Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, 3156 Rampart Road, Fort Collins, CO 80521, USA. Electronic address: ahk7@cdc.gov.<br /><searchLink fieldCode="AU" term="%22Agnihothram+S%22">Agnihothram S</searchLink>; Office of Vaccines Research and Review, Food and Drug Administration, Silver Spring, MD, USA. Electronic address: sudhakar.agnihothram@fda.hhs.gov.<br /><searchLink fieldCode="AU" term="%22Barrett+ADT%22">Barrett ADT</searchLink>; Department of Pathology and Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA. Electronic address: abarrett@utmb.edu.<br /><searchLink fieldCode="AU" term="%22Barzon+L%22">Barzon L</searchLink>; Department of Molecular Medicine, University of Padova, and Microbiology and Virology Unit, Padova University Hospital, Padua, Italy. Electronic address: luisa.barzon@unipd.it.<br /><searchLink fieldCode="AU" term="%22Clements+DE%22">Clements DE</searchLink>; Hawaii Biotech, Inc., Honolulu, HI, USA. Electronic address: clements@hibiotech.com.<br /><searchLink fieldCode="AU" term="%22Durbin+A%22">Durbin A</searchLink>; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. Electronic address: adurbin1@jhu.edu.<br /><searchLink fieldCode="AU" term="%22Kretschmer+M%22">Kretschmer M</searchLink>; Maricopa County Department of Public Health, Phoenix, AZ, USA. Electronic address: melissa.kretschmer@maricopa.gov.<br /><searchLink fieldCode="AU" term="%22Monath+TP%22">Monath TP</searchLink>; Quigley BioPharma LLC, Leominster, MA, USA. Electronic address: tom@quigleybio.com.<br /><searchLink fieldCode="AU" term="%22Mura+M%22">Mura M</searchLink>; Department of Public Health Threats, European Medicines Agency, Amsterdam, Netherlands. Electronic address: manuela.mura@ema.europa.eu.<br /><searchLink fieldCode="AU" term="%22Pierson+TC%22">Pierson TC</searchLink>; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: piersontc@niaid.nih.gov.<br /><searchLink fieldCode="AU" term="%22Prutzman+K%22">Prutzman K</searchLink>; Office of Vaccines Research and Review, Food and Drug Administration, Silver Spring, MD, USA. Electronic address: kirk.prutzman@fda.hhs.gov.<br /><searchLink fieldCode="AU" term="%22Slifka+MK%22">Slifka MK</searchLink>; Najit Technologies, Inc., Beaverton, OR, USA, Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA. Electronic address: mslifka@najittech.com.<br /><searchLink fieldCode="AU" term="%22Suthar+MS%22">Suthar MS</searchLink>; Department of Pediatrics, Center for Childhood Infections and Vaccines, Emory Vaccine Center, Department of Microbiology and Immunology, Emory School of Medicine, Atlanta, GA, USA. Electronic address: msuthar@emory.edu.<br /><searchLink fieldCode="AU" term="%22Whitehead+SS%22">Whitehead SS</searchLink>; Najit Technologies, Inc., Beaverton, OR, USA, Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA; Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: swhitehead@niaid.nih.gov.<br /><searchLink fieldCode="AU" term="%22Staples+JE%22">Staples JE</searchLink>; Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, 3156 Rampart Road, Fort Collins, CO 80521, USA. Electronic address: auv1@cdc.gov. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2025 Dec 05; Vol. 68, pp. 127938. <i>Date of Electronic Publication: </i>2025 Nov 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Conference Proceedings – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41197444 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.vaccine.2025.127938 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 127938 Titles: – TitleFull: Summary of human West Nile virus vaccine meeting, 2024: Investigating barriers to development. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nett RJ – PersonEntity: Name: NameFull: Brault AC – PersonEntity: Name: NameFull: Lambert AJ – PersonEntity: Name: NameFull: Agnihothram S – PersonEntity: Name: NameFull: Barrett ADT – PersonEntity: Name: NameFull: Barzon L – PersonEntity: Name: NameFull: Clements DE – PersonEntity: Name: NameFull: Durbin A – PersonEntity: Name: NameFull: Kretschmer M – PersonEntity: Name: NameFull: Monath TP – PersonEntity: Name: NameFull: Mura M – PersonEntity: Name: NameFull: Pierson TC – PersonEntity: Name: NameFull: Prutzman K – PersonEntity: Name: NameFull: Slifka MK – PersonEntity: Name: NameFull: Suthar MS – PersonEntity: Name: NameFull: Whitehead SS – PersonEntity: Name: NameFull: Staples JE IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 12 Text: 2025 Dec 05 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1873-2518 Numbering: – Type: volume Value: 68 Titles: – TitleFull: Vaccine Type: main |
| ResultId | 1 |